How Glutathione therapy helps Parkinson’s disease
Parkinson’s disease is a devastating illness, occurring in one out of every 100 people over 65. It is a slowly progressing disease of the nervous system that results in progressive destruction of brain cells (neurons) in an area of the brain called the substantia nigra. As we age, levels of glutathione in the neurons of the substantia nigra decreases. At least 80% of the substantia nigra cells are lost before symptoms of Parkinson’s becomes apparent. This is why it is essential to protect or maintain those cells under oxidative stress.
Several factors explain why Glutathione is so beneficial in helping Parkinson’s patients:
1) Glutathione increases the sensitivity of the brain to dopamine, allowing the dopamine in the brain to be more effective
2) Glutathione’s powerful antioxidant activity protects the brain from free radical damage
3) Glutathione has a powerful detoxification ability
Glutathione treatments considerably improve some of the symptoms of Parkinson’s disease including difficulties with ridigity, walking, movement, coordination and speech. A marked reduction of tremor has been observed as well as a decrease in depression